Tulane Receives $15 Million NIH Contract to Develop Vaccine and Treatment for Deadly Fever

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.

Publication - New approach tracks evolution's footprints in the genome

While fossils can provide interesting clues to human history, they can not reveal which pieces of human DNA have been favored by evolution because they present beneficial traits. This information can only be revealed through genetic studies of modern humans and related species.

Syndicate content
PSD to Drupal theme